Pancreatic ductal adenocarcinoma (PDAC) has a bleak prognosis. especially for the majority of patients diagnosed with metastatic disease. The primary option for palliative treatment is chemotherapy. and responses beyond first-line treatment are rare and typically short. https://www.ngetikin.com/